ZIPRASIDONE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Ziprasidone Hydrochloride patents expire, and when can generic versions of Ziprasidone Hydrochloride launch?
Ziprasidone Hydrochloride is a drug marketed by Apotex, Aurobindo Pharma, Chartwell Rx, Dr Reddys Labs Inc, Lupin Pharms, Macleods Pharms Ltd, Mylan, Sandoz Inc, and Zydus Lifesciences. and is included in nine NDAs.
The generic ingredient in ZIPRASIDONE HYDROCHLORIDE is ziprasidone hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ziprasidone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ziprasidone Hydrochloride
A generic version of ZIPRASIDONE HYDROCHLORIDE was approved as ziprasidone hydrochloride by APOTEX on March 2nd, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZIPRASIDONE HYDROCHLORIDE?
- What are the global sales for ZIPRASIDONE HYDROCHLORIDE?
- What is Average Wholesale Price for ZIPRASIDONE HYDROCHLORIDE?
Summary for ZIPRASIDONE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 20 |
| Raw Ingredient (Bulk) Api Vendors: | 93 |
| Clinical Trials: | 146 |
| Patent Applications: | 313 |
| DailyMed Link: | ZIPRASIDONE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for ZIPRASIDONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Shanghai Jiao Tong University School of Medicine | Phase 4 |
| Shanghai Mental Health Center | Phase 4 |
Pharmacology for ZIPRASIDONE HYDROCHLORIDE
| Drug Class | Atypical Antipsychotic |
Anatomical Therapeutic Chemical (ATC) Classes for ZIPRASIDONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for ZIPRASIDONE HYDROCHLORIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| GEODON | Capsules | ziprasidone hydrochloride | 20 mg, 40 mg, 60 mg and 80 mg | 020825 | 5 | 2005-02-07 |
US Patents and Regulatory Information for ZIPRASIDONE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz Inc | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 077562-004 | Jun 1, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 202395-004 | Oct 10, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Lifesciences | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 208988-001 | Aug 22, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz Inc | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 077562-001 | Jun 1, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
